Publications

Predictive performance of wearable sensors for mortality risk in older adults: a model development and validation study

Harper C. et al, (2025)

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

HAYNES R. et al, (2025), EClinicalMedicine

Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England.

Pessoa-Amorim G. et al, (2024), Trials, 25

Association of daily steps with incident non-alcoholic fatty liver disease: Evidence from the UK Biobank cohort

Fulda ES. et al, (2024)

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk None. and Cholesterol Treatment Trialists’ (CTT) Collaboration None., (2024), Lancet Diabetes Endocrinol, 12, 306 - 319

Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.

Sydes MR. et al, (2024), Contemp Clin Trials

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2024), Lancet Child Adolesc Health, 8, 190 - 200

Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson’s Disease: findings from the UK Biobank

Acquah A. et al, (2024)

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2023), Lancet Diabetes Endocrinol, 11, 905 - 914

Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data.

Harper C. et al, (2023), Heart, 109, 1467 - 1472

Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP).

Herrington WG. et al, (2023), Kidney Int Rep, 8, 1489 - 1495

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk None. and RECOVERY Collaborative Group None., (2023), Lancet, 401, 1499 - 1507